Effects of a rhythmic auditory stimulation-enhanced walking program on Veterans with Parkinson’s disease with and without subthalamic nucleus deep brain stimulation.
Objective: Describe outcomes from a 12-week home-based rhythmic auditory stimulation (RAS)-enhanced walking program completed by Veterans with Parkinson’s disease (PD); 1 with subthalamic nucleus deep brain stimulation…Pre-surgical correlates of QoL (PDQ-39) in a DBS eligible PD population
Objective: To investigate the pre-surgical correlates of quality of life (QoL) in patients with Parkinson's disease (PD) eligible for deep brain stimulation (DBS). Background: Optimizing…parkinson’s disease and coffee: is high consumption a protective factor or aversion to coffee taste a risk factor?
Objective: To evaluate the association between coffee consumption and preference for the taste of coffee with Parkinson's Disease (PD). Background: Previous studies point to a…A randomized, phase 2a, double-blind, placebo-controlled clinical trial with NE3107 adjunctive to carbidopa/levodopa in patients with Parkinson’s disease
Objective: To evaluate the motor effects of NE3107 treatment in patients with levodopa-treated Parkinson’s disease (PD) experiencing motor fluctuations. Background: NE3107 is an oral, blood-brain…Depression and Activities of Daily Living in Idiopathic Parkinson’s Disease without Dementia.
Objective: Objective: To study the influence of depression on ADLs in patients with PD in stages I and II of Hoenh and Yahr. Background: Background:…Modulatory effect of posture on prepulse inhibition in Parkinson’s disease and atypical Parkinsonism
Objective: Here, we describe how sPPI from the leg is modulated in different balance conditions in patients with Parkinson’s disease (PD) and progressive supranuclear palsy…Caveats regarding a family with PD and LRRK2 mutations
Objective: To describe and discuss genetic considerations regarding a kindred with PD cases with similar clinical characteristics, some with identified mutations in the LRRK2 gene…Words Spoken Daily: A Novel Measure of Cognition
Objective: To assess the average number of words spoken per day by individuals with Parkinson’s disease (PD), mild cognitive impairment (MCI), and control participants. Background:…Impact of vitamin supplements intake on non-motor fluctuations measured by (NoMoFA) in people living with Parkinson’s disease.
Objective: To determine the impact of vitamins supplements on non-motor fluctuations in people living with Parkinson's disease (PEP). Background: Parkinson's disease (PD) is a neurodegenerative…Prevalence of cardiovascular drugs and oral anticoagulants use among persons with and without Parkinson’s disease
Objective: We investigated prevalence of Cardiovascular drugs and Oral anticoagulants (OAC) use among community-dwelling persons with and without Parkinson's disease (PD) in relation to PD…
- « Previous Page
- 1
- …
- 110
- 111
- 112
- 113
- 114
- …
- 338
- Next Page »